Ikarian Capital, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,077,000
-42.8%
87,071
+5.8%
0.14%
-49.5%
Q4 2021$1,883,000
-57.5%
82,335
-58.8%
0.28%
-9.9%
Q3 2021$4,426,000
+241.0%
200,000
+100.0%
0.31%
+609.1%
Q1 2021$1,298,000
-6.1%
100,0000.0%0.04%
-27.9%
Q4 2020$1,383,000
-6.2%
100,0000.0%0.06%
-43.0%
Q3 2020$1,474,000
-72.3%
100,000
-69.5%
0.11%
-74.8%
Q2 2020$5,326,000
+15.2%
327,771
+2.8%
0.42%
+21.8%
Q1 2020$4,625,000
-52.5%
318,771
-33.7%
0.35%
-78.0%
Q4 2019$9,747,000481,1041.58%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders